$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
How long does it take for gefitinib to be effective?
2025-10-19 11:44:20
Check Details
Instructions for use of Osimertinib
2025-10-19 11:44:20
Check Details
Osimertinib medical insurance price in 2021
2025-10-19 11:44:20
Check Details
What are the taboos when taking osimertinib?
2025-10-19 11:44:20
Check Details
Should I take Osimertinib long-term?
2025-10-19 11:44:20
Check Details
AMG 757 shows early efficacy and safety in small cell lung cancer_Canghule
2025-10-19 11:44:20
Check Details
How long does resistance to osimertinib last?
2025-10-19 11:44:20
Check Details
The best time to take osimertinib
2025-10-19 11:44:20
Check Details
The latest data confirms the significant clinical benefit of entrectinib in the treatment of ROS1 fusion non-small cell lung cancer_ Kanghule
2025-10-19 11:44:20
Check Details
Inventory of targeted therapies for early treatment of non-small cell lung cancer
2025-10-19 11:44:20
Check Details
Safety dosing study of twice-daily pozitinib monotherapy in NSCLC_ Kanghule
2025-10-19 11:44:20
Check Details
Instructions for Icotinib
2025-10-19 11:44:20
Check Details
1
2
...
3847
3848
3849
3850
3851
3852
3853
...
4152
4153
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Pimitespib Storage Guidelines: Temperature, Humidity & Light Control for Home Use
2
Cemiplimab (Libtayo) Drug Information
3
Mirvetuximab Soravtansine (Elahere): FRα-Targeted ADC for Platinum-Resistant Ovarian Cancer
4
The Cornerstone Therapy for Adrenocortical Carcinoma and Global Guidelines Update
5
Trodelvy® (Sacituzumab Govitecan-hziy): A Life-Changing ADC for Advanced Cancers
6
A Revolutionary Targeted Therapy for Hematological Malignancies
7
A New Option for Advanced Renal Cell Carcinoma Treatment
8
Trametinib (Mekinist): Precision MEK1/2 Inhibition Transforming Cancer Care Short Description:
9
Pirtobrutinib: A Novel BTK Inhibitor Offering Hope for Hematologic Cancer Patients Short Description:
10
Sacituzumab Govitecan: Trop-2 Targeted ADC Clinical Medication Guide
11
Fulvestrant (Faslodex) Breast Cancer Guide: Indications, Dosage and Safety Specifications
12
Adagrasib (Krazati): Full Guide to KRAS G12C Inhibitor for Cancer Treatment